Crossmark

Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures

Crossref DOI link: https://doi.org/10.1136/lupus-2019-000365

Published Online: 2019-12-30

Published Print: 2019-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Thanou, Aikaterini https://orcid.org/0000-0002-1161-7618
James, Judith A

Arriens, Cristina https://orcid.org/0000-0002-9546-1664
Aberle, Teresa

Chakravarty, Eliza

Rawdon, Joseph

Stavrakis, Stavros

Merrill, Joan T

Askanase, Anca
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct02270957 at ClinicalTrials.gov

Documents that mention this clinical trial

Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures
https://doi.org/10.1136/lupus-2019-000365

CS-05 Can systemic lupus erythematosus (SLE) disease activity be consistently scored and interpreted with simple, rapid outcome measures?
https://doi.org/10.1136/lupus-2018-lsm.40
Funding

Funding for this research was provided by:

Bristol-Myers Squibb